Votre sélection est vide.
Sélectionnez des ETF pour les comparer les uns aux autres.
Ajoutez un ETF à la sélection en le sélectionnant dans le sélecteur d’ETF ou sous « Comparer » sous le profil de l’ETF.
| Index | Russell 2000® |
| Investment focus | Actions, États-Unis, Small Cap |
| Fund size | EUR 641 m |
| Total expense ratio | 0,35% p.a. |
| Replication | Synthetic (Unfunded swap) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | Non |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 18,14% |
| Inception/ Listing Date | 7 janvier 2014 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Luxembourg |
| Fund Provider | Amundi ETF |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | CACEIS Bank, Luxembourg Branch |
| Investment Advisor | |
| Custodian Bank | CACEIS Bank, Luxembourg Branch |
| Revision Company | PWC |
| Fiscal Year End | 30 septembre |
| Swiss representative | CACEIS (Switzerland) SA |
| Swiss paying agent | CACEIS Bank, Paris, succursale de Nyon / Suisse |
| Germany | 30% d’exonération partielle |
| Switzerland | ESTV Reporting |
| Austria | Meldefonds |
| UK | UK Reporting |
| Italy | 26,0% |
| Indextype | Total return index |
| Swap counterparty | BNP Paribas |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| JFrog | 0,34% |
| Moog | 0,34% |
| UMB Financial | 0,34% |
| Glaukos | 0,33% |
| Brinker International | 0,32% |
| BrightSpring Health Svcs | 0,31% |
| Cytokinetics | 0,30% |
| Twist Bioscience | 0,29% |
| Krystal Biotech | 0,29% |
| FirstCash Holdings | 0,29% |
| États-Unis | 95,11% |
| Îles des Bermudes | 1,66% |
| Autre | 3,23% |
| Finance | 26,35% |
| Soins de santé | 20,72% |
| Technologie | 11,75% |
| Industrie | 10,38% |
| Autre | 30,80% |
| YTD | +19.18% |
| 1 month | -0.04% |
| 3 months | -4.11% |
| 6 months | +11.43% |
| 1 year | +18.35% |
| 3 years | +54.60% |
| 5 years | +36.31% |
| Since inception (MAX) | +231.95% |
| 2025 | -1.05% |
| 2024 | +18.57% |
| 2023 | +12.63% |
| 2022 | -15.55% |
| Volatility 1 year | 18.14% |
| Volatility 3 years | 20.94% |
| Volatility 5 years | 22.02% |
| Return per risk 1 year | 1.01 |
| Return per risk 3 years | 0.75 |
| Return per risk 5 years | 0.29 |
| Maximum drawdown 1 year | -9.01% |
| Maximum drawdown 3 years | -30.42% |
| Maximum drawdown 5 years | -30.42% |
| Maximum drawdown since inception | -41.65% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | RS2K | - - | - - | - |
| Bourse de Stuttgart | EUR | RS2K | - - | - - | - |
| Borsa Italiana | EUR | RS2K | RS2K IM IRS2K | RS2K.MI IRS2KINAV.PA | BNP Paribas Arbitrage |
| Borsa Italiana | EUR | - | RS2K IM IRS2K | RS2K.MI INRS2K=BNPP | BNP Paribas Arbitrage |
| Euronext Paris | EUR | RS2K | RS2K FP IRS2K | RS2K.PA INRS2K=BNPP | BNP Paribas Arbitrage |
| SIX Swiss Exchange | EUR | RS2K | RS2K SW IRS2K | RS2K.S INRS2K=BNPP | BNP Paribas Arbitrage |
| XETRA | EUR | RS2K | RS2K GY IRS2K | RS2K.DE INRS2K=BNPP | BNP Paribas Arbitrage |
| Nom du fonds | Taille du fonds en M € (AuM) | Frais annuels | Distribution | Réplication |
|---|---|---|---|---|
| WisdomTree Russell 2000 | 7 | 0,20% p.a. | Capitalisation | Synthétique |
| Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Dist | 3 | 0,20% p.a. | Distribution | Complète |